Yu BB - Search Results

1

Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area.

Guan Y, Han L, Luo HY, Yu BB, Huang ST. Guan Y, et al. Among authors: yu bb. World J Surg Oncol. 2024 Jul 11;22(1):180. doi: 10.1186/s12957-024-03460-z. World J Surg Oncol. 2024. PMID: 38987785 Free PMC article.

2

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.

Liang ZG, Chen XQ, Lin GX, Yu BB, Chen KH, Zhong QL, Nong SK, Li L, Qu S, Su F, Zhao W, Li Y, Zhu XD. Liang ZG, et al. Among authors: yu bb. Sci Rep. 2017 Feb 2;7:41449. doi: 10.1038/srep41449. Sci Rep. 2017. PMID: 28150694 Free PMC article.

3

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma.

Liang ZG, Zhang F, Yu BB, Li L, Qu S, Li Y, Guan Y, Liang RB, Han L, Zhu XD. Liang ZG, et al. Among authors: yu bb. Cancer Manag Res. 2020 Feb 4;12:801-812. doi: 10.2147/CMAR.S236128. eCollection 2020. Cancer Manag Res. 2020. PMID: 32099476 Free PMC article.

4

The Integration of the Pre-Treatment Neutrophil-to-Lymphocyte Ratio in the Eighth Edition of the AJCC Staging System for Nasopharynx Cancer.

Liang ZG, Zhang F, Li Y, Li L, Qu S, Su F, Yu BB, Guan Y, Han L, Li KG, Zhu XD. Liang ZG, et al. Among authors: yu bb. Front Oncol. 2021 Nov 11;11:724467. doi: 10.3389/fonc.2021.724467. eCollection 2021. Front Oncol. 2021. PMID: 34858812 Free PMC article.

5

Research trends of radiation induced temporal lobe injury in patients with nasopharyngeal carcinoma from 2000 to 2022: a bibliometric analysis.

Guan Y, Yu BB, Liu S, Luo HY, Huang ST. Guan Y, et al. Among authors: yu bb. Radiat Oncol. 2023 Sep 13;18(1):151. doi: 10.1186/s13014-023-02345-x. Radiat Oncol. 2023. PMID: 37705085 Free PMC article.

6

Treatment Patterns and Survival Outcomes in Patients With Stage T1-2N0M0 Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study.

Huang JQ, Liang HW, Liu Y, Chen L, Pei S, Yu BB, Huang W, Pan XB. Huang JQ, et al. Among authors: yu bb. World J Oncol. 2024 Feb;15(1):126-135. doi: 10.14740/wjon1765. Epub 2024 Jan 10. World J Oncol. 2024. PMID: 38274725 Free PMC article.

7

Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Huang JQ, Liang HW, Liu Y, Chen L, Pei S, Yu BB, Pan XB. Huang JQ, et al. Among authors: yu bb. Front Immunol. 2024 Mar 14;15:1355198. doi: 10.3389/fimmu.2024.1355198. eCollection 2024. Front Immunol. 2024. PMID: 38550598 Free PMC article.

8

Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study.

Yu BB, Huang JQ, Liang HW, Liu Y, Chen L, Pei S, Huang W, Pan XB. Yu BB, et al. Aging (Albany NY). 2024 Apr 18;16(8):7131-7140. doi: 10.18632/aging.205747. Epub 2024 Apr 18. Aging (Albany NY). 2024. PMID: 38643464 Free PMC article.

9

Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study.

Liu Y, Ma J, Zeng XY, Zuo ZC, Chen RZ, Li XY, Liang ZG, Chen KH, Pan XB, Pei S, Yu BB, Li L, Qu S, Yang YL, Zhu XD. Liu Y, et al. Among authors: yu bb. Radiother Oncol. 2024 Jul;196:110311. doi: 10.1016/j.radonc.2024.110311. Epub 2024 Apr 24. Radiother Oncol. 2024. PMID: 38670263 Free article.

10

Nomograms to predict the long-term prognosis for non-metastatic invasive lobular breast carcinoma: a population-based study.

Guan Y, Huang ST, Yu BB. Guan Y, et al. Among authors: yu bb. Sci Rep. 2024 Aug 22;14(1):19477. doi: 10.1038/s41598-024-68931-5. Sci Rep. 2024. PMID: 39174612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters